Products for Research Use Only
RegisterLogin

Lemzoparlimab

CAT: 0804-HY-P99026-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99026-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Lemzoparlimab (TJ011133; TJC4) is a humanized anti-CD47 IgG4 antibody. Lemzoparlimab has a strong anti-tumor activity[1].
CAS Number
2377483-71-9
Product Name Alternative
TJ011133; TJC4
UNSPSC
12352203
Target
CD47
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/lemzoparlimab.html
Purity
99.31
Solubility
H2O
Smiles
[Lemzoparlimab]
Molecular Weight
(145.58 kDa)
References & Citations
[1]Amitkumar Mehta, et al. Lemzoparlimab, a Differentiated Anti-CD47 Antibody in Combination with Rituximab in Relapsed and Refractory Non-Hodgkin's Lymphoma: Initial Clinical Results. Blood (2021) 138 (Supplement 1) : 3542.|[2]Jiang Z, et al., Targeting CD47 for cancer immunotherapy. J Hematol Oncol. 2021 Oct 30;14 (1) :180.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
MBS1563116-01Lemzoparlimab
GTR18398549-01Lemzoparlimab Antibody
HC359036-01Research Grade Lemzoparlimab
C00661-1mg*25Lemzoparlimab (Anti-CD47)
047853CD47 (lemzoparlimab) discontinued
E55B0798Lemzoparlimab (Reference antibody)
MBS3030393-01Lemzoparlimab Biosimilar - Research Grade
ABS-310-1mgLemzoparlimab Biosimilar, Research Grade
21-924Lemzoparlimab - Research Grade Biosimilar
F1165-50Anti-CD47 Antibody (Lemzoparlimab)

Popular Products